Home » Topics » BioWorld Science

BioWorld Science
RSS

Domain Therapeutics patents mGluR4 positive allosteric modulators

Feb. 17, 2020

New IDO-1 inhibitors identified at Bristol-Myers Squibb

Feb. 17, 2020

High affinity nerve growth factor receptor inhibitors presented by JC Pharma

Feb. 17, 2020

Hinova Pharmaceuticals discovers new BRD4 inhibitors

Feb. 17, 2020

Preliminary data presented from POLARIS-03 study of toripalimab in UC

Feb. 17, 2020

Bayer presents data from phase II/III FORT-1 study of rogaratinib

Feb. 17, 2020

Phase I data presented for fosciclopirox in advanced solid tumors

Feb. 17, 2020

GeneTx receives approval to initiate phase I/II study GTX-102

Feb. 17, 2020

Sihuan Pharmaceutical initiates phase III study of anaprazole sodium in duodenal ulcer

Feb. 17, 2020

Positive data for RECCE-327 in models of kidney and UTI infection

Feb. 17, 2020

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 2, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 30, 2026
Deep brain stimulation from the shallows: tomorrow’s BCI technology?
BioWorld
Deep brain stimulation (DBS) through implanted electrodes has enabled fundamentally new ways of treating certain disorders. More than 100,000 severely ill...
CINP 2026: organoids reveal autism and addiction mechanisms
BioWorld Science
At the 2026 World Congress of Neuropsychopharmacology (CINP), held in Glasgow June 26-29, 2026, researchers from Japan’s National Center of Neurology and...
Deerfield-backed Boulevard, Metis pen $1.6B trispecific TCE deal
BioWorld
A U.S. biotechnology company founded by Deerfield Management Company L.P. licensed exclusive rights to Metis Techbio Co. Ltd.’s preclinical trispecific T-cell...